Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions
BioAge CEO Kristen Fortney sits down with Fierce Editor-in-Chief Ayla Ellison to discuss aging biology, inflammation and NLRP3 drugs.
Ayla Ellison
May 22, 2026 10:00am
Roivant’s CEO thinks China is a ‘red herring’
Apr 17, 2026 8:35am
What Xaira is building after its $1B fundraise
Mar 20, 2026 10:34am
What were the biggest clinical trial flops of 2025?
Feb 13, 2026 11:47am
Designing Clinical Trials Balancing Simplicity with Complexity
Jan 27, 2026 12:00am
Biotech Graveyard
Oct 31, 2025 9:41am
